Posts
November 29 2016
Bellerophon Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $12,000.000. EG&S acted as counsel to the Placement Agent.
November 29 2016
Cellectar Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $9,200,000. EG&S acted as counsel to the Underwriter.
November 29 2016
Rosetta Genomics Ltd. announced the closing of their PIPE offering in the amount of $3,707,500. EG&S acted as counsel to the Investor.
November 23 2016
Client Alert: Federal Judge Blocks Implementation
As we previously advised, on May 18, 2016, the U.S. Department of Labor published the final rule updating the overtime regulations. Click here to read the full alert.
November 23 2016
MotifBio PLC announced the closing of their Underwritten offering in the amount of $17,020,667. EG&S acted as counsel to the Underwriter.
November 21 2016
MagneGas Corporation announced the closing of their Shelf offering in the amount of $3,000,000. EG&S acted as counsel to the Investor.
November 09 2016
Bridgeline Digital Inc. announced the closing of their PIPE offering in the amount of $1,091,901. EG&S acted as counsel to the Placement Agent.
November 03 2016
Sunshine Heart, Inc. announced the closing of their Registered Direct offering in the amount of $3,600,000. EG&S acted as counsel to the Placement Agent.